60¢sixtycents

GSK plcGSK

$50.67-1.48 (-2.84%)
NYSEHealthcare24:00 UTC

Company snapshot

Market Cap
$103B
Large-cap
+23%
2016 — today
10-Year Price
+18%
2016 — today
52-Week Range
$36.20$61.18
Current $50.67· 58%

GSK plc (formerly GlaxoSmithKline) researches, develops, and manufactures vaccines and specialty medicines globally. Organized into Commercial Operations and R&D, its portfolio includes immunizations for shingles, meningitis, RSV, and influenza, alongside treatments for HIV, oncology, respiratory conditions (asthma/COPD), and infections. Innovation is driven by strategic partnerships, including mRNA vaccine development with CureVac, oligonucleotide platforms with Wave Life Sciences, and research alliances for Parkinson’s and fibrotic diseases.

Valuation in context

P/E ratio
15.1
Historically cheap
Historically cheap relative to the last 10 years
P/B ratio
4.5
Below average
Below the 10-year average
EV / EBITDA
11.0
Below average
Below the 10-year average
Dividend Yield
3.6%
Near historic low
Near historic low — last 10 years
PEG ratio
3.0
Above average
Pricier than usual over the last 10 years
FCF Yield
6.0%
Below average
Below the 10-year average
Free · No credit card needed

Get alerted when GSK is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.